ANGIODYNAMICS INC

By person

26 insiders · 68 transactions

15.8×

James C. Clemmer holds 15.8 times base salary in stock. $12.70M of shares against $803.03K in salary for 2025.

Salary from the company's own proxy. The shares are what James C. Clemmer last reported holding, valued at $14.72, the price Common Stock was last bought or sold at on the open market here, on 30 Jul 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Avista Capital Partners GP, LLC entity

10% owner

—

$70.39M (5)

−$70.39M

381,406

0.9228%

$5.61M

−92.7%

Burgstahler David F

Director

—

$70.39M (5)

−$70.39M

405,394

0.9808%

$5.97M

−92.3%

Clemmer James C

President and CEO

$1.61M (9)

—

+$1.61M

862,448

2.09%

$12.70M

+1,286%

Richard Stark

SVP, GM - Oncology

—

$446.49K (1) scheduled

−$446.49K

20,754

0.0502%

$305.50K

+12.6%

Helsel Dave

SVP Global Operations and R&D

—

$432.51K (5)

−$432.51K

28,289

0.0684%

$416.41K

+62.0%

Nighan Warren JR

SVP Quality and Regulatory

$5.29K (2)

$393.99K (2)

−$388.70K

64,745

0.1566%

$953.05K

+264.0%

Centea Scott

SVP/GM, VIT

—

$335.04K (1) scheduled

−$335.04K

58,128

0.1406%

$855.64K

+33.1%

JOHNSON WESLEY

Director

—

$293.28K (3)

−$293.28K

155,425

0.3760%

$2.29M

+299.8%

Gould Kevin J

Director

—

$292.79K (1) scheduled

−$292.79K

77,504

0.1875%

$1.14M

+141.5%

Campbell Chad Thomas

SVP/GM, Vascular Access

—

$291.81K (1) scheduled

−$291.81K

108,676

0.2629%

$1.60M

+527.2%

Weiss Lawrence T

SVP, Chief Legal Officer

$118.10K (1)

—

+$118.10K

91,330

0.2210%

$1.34M

—

DONNELLY HOWARD W

Director

$78.60K (1)

—

+$78.60K

178,938

0.4329%

$2.63M

+324.6%

Trowbridge Stephen A

EVP and CFO

$67.00K (5)

—

+$67.00K

305,796

0.7398%

$4.50M

+614.1%

Greiner Michael

EVP and CFO

—

$41.75K (1)

−$41.75K

33,438

0.0809%

$492.21K

+234.4%

REED JAN STERN

Director

$5.06K (1)

—

+$5.06K

116,921

0.2829%

$1.72M

—

Meteny Dennis S

Director

—

140,019

0.3388%

$2.06M

+132.6%

Auen Eileen O'Shea

Director

—

116,605

0.2821%

$1.72M

—

Licitra Karen A

Director

—

102,322

0.2476%

$1.51M

—

Tarnoff Michael E

Director

—

95,265

0.2305%

$1.40M

—

GOLD JEFFREY

Director

—

83,640

0.2024%

$1.23M

+60.7%

Piccinini Laura

SVP International

—

81,929

0.1982%

$1.21M

—

Burgess Lorinda

Director

—

67,144

0.1624%

$988.36K

—

LaPorte Steve

Director

—

48,484

0.1173%

$713.68K

+41.8%

ROSENZWEIG RICHARD C

SVP and General Counsel

—

15,730

0.0381%

$231.55K

—

Simpson Robert Arthur

SVP/GM, Global Vascular

—

15,441

0.0374%

$227.29K

—

Boucher Brent J.

SVP and GM of Oncology

—

15,416

0.0373%

$226.92K

+9.9%

Individual transactions

Insider

Date

Role

Action

Price

Amount

Nighan Warren JR

30 Jul 2026

SVP Quality and Regulatory

Sell

23,370

$14.72

$344.01K

Nighan Warren JR

16 Jan 2025

SVP Quality and Regulatory

Sell

4,060

$12.31

$49.98K

Helsel Dave

31 Jan 2023

SVP Global Operations and R&D

Sell

4,633

$12.95

$60.00K

Helsel Dave

29 Jul 2022

SVP Global Operations and R&D

Sell

5,000

$22.44

$112.20K

Helsel Dave

28 Apr 2022

SVP Global Operations and R&D

Sell

3,513

$22.44

$78.83K

JOHNSON WESLEY

12 Apr 2022

Director

Sell

1,299

$23.26

$30.21K

JOHNSON WESLEY

11 Apr 2022

Director

Sell

6,201

$23.00

$142.62K

Helsel Dave

20 Oct 2021

SVP Global Operations and R&D

Sell

3,494

$27.97

$97.73K

Helsel Dave

14 Apr 2021

SVP Global Operations and R&D

Sell

3,500

$23.93

$83.76K

JOHNSON WESLEY

20 Jan 2021

Director

Sell

6,500

$18.53

$120.45K

Greiner Michael

7 Nov 2018

EVP and CFO

Sell

1,939

$21.53

$41.75K

Avista Capital Partners GP, LLC

12 Apr 2017

10% owner

Sell indirect

384,184

$16.00

$6.15M

Avista Capital Partners GP, LLC

12 Apr 2017

10% owner

Sell indirect

508,869

$16.00

$8.14M

Avista Capital Partners GP, LLC

12 Apr 2017

10% owner

Sell indirect

1,456,947

$16.00

$23.31M

Burgstahler David F

12 Apr 2017

Director

Sell indirect

384,184

$16.00

$6.15M

Burgstahler David F

12 Apr 2017

Director

Sell indirect

508,869

$16.00

$8.14M

Burgstahler David F

12 Apr 2017

Director

Sell indirect

1,456,947

$16.00

$23.31M

Avista Capital Partners GP, LLC

18 Nov 2016

10% owner

Sell indirect

541,349

$15.68

$8.49M

Avista Capital Partners GP, LLC

18 Nov 2016

10% owner

Sell indirect

1,549,945

$15.68

$24.30M

Burgstahler David F

18 Nov 2016

Director

Sell indirect

541,349

$15.68

$8.49M

Burgstahler David F

18 Nov 2016

Director

Sell indirect

1,549,945

$15.68

$24.30M

Show all 68 transactions →

By person

Individual transactions

What was left out